Real-time enrollment status for this ataxia telangiectasia clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06664853 |
| Recruiting Status | Terminated |
| Condition | Ataxia Telangiectasia |
| Phase | Clinical Trial |
| Target Enrollment | 106 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Quince Therapeutics S.p.A. |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06664853 is currently terminated participants. This clinical trial study for ataxia telangiectasia is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Quince Therapeutics S.p.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06664853 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06664853 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.